Carcinogenic bacteria

Lore & Background

The history of carcinogenic bacteria includes early 20th-century claims by researchers such as William Russell, who in 1890 described peculiar cellular inclusions in cancer tissues. These structures, now known as Russell bodies, were initially speculated by some to be related to a bacterial cause of cancer, though this interpretation has since been abandoned. In 1926, Canadian physician Thomas Glover reported isolating a specific bacterium from neoplastic tissues and claimed a serum from it gave remarkable results in 50 cases. Glover's work was challenged by scientists from the Public Health Service, and he refused to repeat his research for quality control; his claims are today not given serious merit.

In 1950, Virginia Livingston published a paper claiming a specific Mycobacterium was associated with neoplasia, later proposing the name Progenitor cryptocides and a treatment protocol.

Reader's Guide

Carcinogenic bacteria represent a significant shift in understanding cancer etiology, moving beyond the view that bacteria are merely opportunistic. The strongest evidence centers on Helicobacter pylori, a Class 1 carcinogen that can cause stomach cancer and MALT lymphoma. Animal models have demonstrated Koch's third and fourth postulates for H. pylori in stomach cancer causation. The mechanisms involve chronic inflammation, where H. pylori infection recruits immune cells that produce reactive oxygen and nitrogen species, causing DNA damage while the bacterium down-regulates DNA repair pathways, leading to genomic instability. Additionally, the virulence factor CagA alters cell signaling, activates pro-inflammatory pathways, increases cell proliferation, and inhibits tumor suppressor genes via hypermethylation. Despite historical controversies and unsubstantiated claims of a universal cancer bacterium, the established link between H. pylori and gastric cancer has influenced cancer prevention and treatment strategies. Other bacteria, such as Salmonella Typhi linked to gallbladder cancer and gut bacteria possibly related to colon cancer, remain speculative. The relationship between cancer and bacteria may be complicated by individual variations in response to different cancers.

Did You Know?

• Helicobacter pylori is described as a Class 1 carcinogen and can cause stomach cancer and MALT lymphoma.
• The virulence factor CagA in H. pylori can change cell signaling and activate the PI3K/Akt pathway, often overly active in many human cancers.
• H. pylori down-regulates major DNA repair pathways, leading to genomic instability in gastric cells.
• In 1990, the National Cancer Institute concluded that Virginia Livingston's claimed cancer bacterium was actually Staphylococcus epidermidis.

The Inflammatory Pathway to Gastric Cancer

H. pylori, a bacterium that takes up residence in the human stomach and duodenum, stands as the strongest confirmed bacterial link to malignancy, classified as a Class 1 carcinogen capable of producing stomach cancer and MALT lymphoma. Animal studies have satisfied Koch's third and fourth postulates, lending experimental weight to its causal role. The central mechanism revolves around persistent inflammation. When the bacterium colonizes gastric tissue, it triggers a massive recruitment of circulating immune cells, particularly neutrophils, which flood the site with antimicrobial weapons including reactive oxygen species and reactive nitrogen species. H. pylori itself evades this oxidative assault by manufacturing antioxidant enzymes like catalase, but the collateral damage to surrounding host cells is severe. Excess reactive species inflict multiple forms of DNA damage on gastric epithelial cells. Compounding the problem, the bacterium simultaneously suppresses the cell's major DNA repair machinery. The net effect is a progressive accumulation of genomic and mitochondrial mutations, driving the kind of genomic instability that is a recognized hallmark of cancer.

CagA: A Molecular Weapon Against the Host Cell

Beyond the general inflammatory damage, H. pylori wields a specific virulence factor called CagA that directly rewires the signaling landscape of infected gastric cells. Once injected into the host cell cytoplasm, CagA operates through both phosphorylation-dependent and phosphorylation-independent routes. In its phosphorylated form, it disrupts normal cell adhesion, spreading, and migration while simultaneously triggering the release of the proinflammatory chemokine IL-8. In its non-phosphorylated state, a region called the CRPIA motif drives persistent activation of the PI3K/Akt pathway, a signaling cascade that is characteristically hyperactive across many human cancers. This sustained activation cascades into the NF-κB and β-catenin pathways, pushing gastric cells toward uncontrolled proliferation. CagA also promotes hypermethylation of tumor suppressor genes by upregulating the methyltransferase DNMT1 through the AKT–NF-κB axis, effectively silencing the cell's own cancer-prevention mechanisms. Finally, CagA induces the enzyme spermine oxidase, which converts spermine to spermidine and generates hydrogen peroxide as a byproduct, further amplifying the oxidative stress already present in chronically inflamed tissue.

A Controversial Century of Bacterial Cancer Theories

Long before H. pylori earned its carcinogen designation, several researchers attempted to link bacteria to cancer with mixed and often disputed results. In 1890, Scottish pathologist William Russell presented circumstantial evidence suggesting a bacterial origin for cancer. A more ambitious claim came in 1926 from Canadian physician Thomas Glover, who reported isolating a pleomorphic organism from neoplastic tissues in both animals and humans, and claimed a derived serum produced remarkable results in fifty patient cases. Glover was invited to continue his work at the Public Health Service, which later became part of the National Institutes of Health, and published his findings in 1930. When PHS scientists requested he repeat his experiments under stricter quality controls, Glover declined and continued independently, and his claims have since been largely dismissed. In 1950, Virginia Livingston of Newark proposed that a specific Mycobacterium was tied to neoplasia and named it Progenitor cryptocides. A 1990 National Cancer Institute review found her classification contained remarkable errors, identifying the organism as nothing more than Staphylococcus epidermidis. Other figures from the 1930s through 1960s, including William Coley and Eleanor Alexander-Jackson, also explored bacterial links to cancer.

Beyond H. pylori: Speculative Bacterial Links to Cancer

While H. pylori remains the gold standard for bacterial carcinogenesis, a wider web of associations exists where the causal role of bacteria stays uncertain. Salmonella Typhi has been linked to gallbladder cancer, yet the same organism has also been explored as a potential vehicle for delivering chemotherapeutic agents against melanoma, colon, and bladder cancers. Gut microbiota may play a role in colon cancer, though the picture is muddied by the presence of chemoprotective probiotic bacteria that could counteract harmful effects. Microorganisms and their metabolic byproducts, or the chronic inflammation they provoke, have also been tentatively connected to oral cancers. The relationship between bacteria and cancer is further complicated by individual variability; different patients respond differently to the same microbial exposures, and the same bacterial species may interact with different tissue contexts in unpredictable ways. It is also worth noting that oncoviruses occupy a parallel niche as viral agents suspected of causing cancer, suggesting that infectious agents broadly—whether bacterial or viral—may contribute to malignant transformation in ways still not fully understood. Historically, cancer-associated bacteria were dismissed as mere opportunists colonizing already-damaged tissue, but the evidence now points toward a more active, potentially initiating role.